Dec 14, 2017 9:00 AM EST
Galectin Therapeutics 2017 Annual Meeting of Shareholders - Corporate Update

Corporate Profile

Galectin Therapeutics is a biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to create new therapies to improve the lives of patients with chronic liver and skin diseases and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function... (more)